Status:
TERMINATED
1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
Lead Sponsor:
Alcon Research
Collaborating Sponsors:
PPD Development, LP
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Parallel, Multi-Center, Double-masked, Active controlled, three arm study comparing the IOP lowering efficacy and safety over 12 months of morning or evening instillations of Travoprost/Brinzolamide v...
Eligibility Criteria
Inclusion
- IOP at screening visit \<18mmHg in at least one eye Mean IOP in same eye (at both eligibility 1 \&2 visits)
- 24 and ≤ 36 mmHg at 9:00
- 21 and ≤ 36 mmHg at 11:00 and 16:00
Exclusion
- Severe central visual field loss Angle Shaffer grade \< 2 C/D ratio \> 0.8 (horizontal or vertical measurement)
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00767481
Start Date
October 1 2008
End Date
February 1 2009
Last Update
July 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mexico City, Mexico, 6700